KLF4 and acute lymphoblastic leukemia: Genetic or pharmacological induction of KLF4 inhibits the proliferation of TAL1‐positive T‐ALL cells by downregulating TAL1 expression through the suppression of TAL1 super‐enhancer activity [8].